[A new antianginal drug, bepridil: efficacy estimation by exertion test during a double blind test against a placebo (author's transl)].
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D015764:Bepridil; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D004311:Double-Blind Method; D005080:Exercise Test; D006801:Humans; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D011759:Pyrrolidines / Q000494:pharmacology*
D011759:Pyrrolidines; D015764:Bepridil
Un nouvel antiangoreux, le bépridil. Appréciation de son efficacité par l'épreuve d'effort au cours d'un assai à double insu contre placebo.